Wijnand Helfrich Selected Research

Wijnand Helfrich Research Topics

Disease

50	Neoplasms (Cancer) 07/2023 - 04/2002
12	Prostatic Neoplasms (Prostate Cancer) 04/2021 - 07/2009
9	Carcinoma (Carcinomatosis) 01/2023 - 03/2004
7	Melanoma (Melanoma, Malignant) 03/2022 - 11/2010
5	Ovarian Neoplasms (Ovarian Cancer) 07/2023 - 01/2010
3	Neoplasm Metastasis (Metastasis) 01/2022 - 07/2009
3	Ovarian Epithelial Carcinoma 10/2018 - 01/2010
2	Triple Negative Breast Neoplasms 03/2016 - 01/2016
2	Rheumatoid Arthritis 09/2014 - 01/2011
2	Infections 06/2013 - 12/2008
2	Brain Neoplasms (Brain Tumor) 07/2007 - 05/2006
2	Lymphoma (Lymphomas) 02/2007 - 04/2005
2	Leukemia 04/2006 - 04/2005
2	T-Cell Leukemia (Leukemia, T Cell) 04/2006 - 04/2005
1	Photophobia (Light Sensitivity) 02/2024
1	Glioblastoma (Glioblastoma Multiforme) 07/2023
1	Cytokine Release Syndrome 01/2023
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2019
1	Lung Neoplasms (Lung Cancer) 01/2019
1	Bites and Stings (Sting) 01/2019
1	Breast Neoplasms (Breast Cancer) 03/2016
1	Sarcoma (Soft Tissue Sarcoma) 01/2015
1	Colorectal Neoplasms (Colorectal Cancer) 01/2015

Drug/Important Bio-Agent (IBA)

18	Proteins (Proteins, Gene)FDA Link 02/2024 - 03/2004
16	AntigensIBA 03/2022 - 03/2004
15	AntibodiesIBA 07/2023 - 04/2002
9	Epithelial Cell Adhesion MoleculeIBA 07/2023 - 03/2004
8	Immunoglobulin FragmentsIBA 01/2023 - 04/2006
8	LigandsIBA 10/2017 - 03/2005
7	Peptides (Polypeptides)IBA 07/2023 - 07/2009
5	ErbB Receptors (EGF Receptor)IBA 01/2019 - 03/2005
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2015 - 04/2002
5	Bombesin Receptors (Bombesin Receptor)IBA 10/2013 - 07/2009
4	RadiopharmaceuticalsIBA 01/2021 - 08/2011
4	TNF-Related Apoptosis-Inducing LigandIBA 08/2016 - 03/2004
4	Monoclonal AntibodiesIBA 01/2015 - 03/2005
4	BombesinIBA 10/2013 - 08/2011
3	beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA 07/2023 - 08/2021
3	Adenosine (Adenocard)FDA LinkGeneric 07/2023 - 08/2021
3	Adenosine Triphosphate (ATP)IBA 07/2023 - 08/2021
3	Surface Antigens (Surface Antigen)IBA 01/2023 - 03/2004
3	chondroitin sulfate proteoglycan 4IBA 11/2019 - 01/2016
3	Rituximab (Mabthera)FDA Link 01/2019 - 08/2006
3	VaccinesIBA 10/2018 - 01/2010
3	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 02/2016 - 03/2004
2	Immune Checkpoint InhibitorsIBA 01/2023 - 11/2019
2	Antigen-Antibody Complex (Immune Complex)IBA 01/2023 - 04/2002
2	Cytotoxins (Cytolysins)IBA 01/2023 - 05/2006
2	AzidesIBA 04/2021 - 08/2020
2	Alkynes (Acetylenes)IBA 04/2021 - 08/2020
2	Bispecific AntibodiesIBA 01/2019 - 05/2008
2	Glycoproteins (Glycoprotein)IBA 06/2017 - 08/2008
2	Immunoglobulin G (IgG)IBA 01/2015 - 04/2002
2	Immunotoxins (Immunotoxin)IBA 10/2014 - 05/2013
2	temoporfinIBA 10/2014 - 05/2012
2	Radioisotopes (Radionuclides)IBA 06/2014 - 08/2012
2	Technetium (Technetium 99m)IBA 10/2013 - 08/2011
2	bombesin (7-14)IBA 10/2013 - 08/2011
2	tricineIBA 10/2013 - 08/2011
2	rimcazoleIBA 09/2013 - 11/2010
2	Death Domain ReceptorsIBA 05/2013 - 02/2007
2	Gefitinib (Iressa)FDA Link 08/2006 - 03/2005
2	Bortezomib (Velcade)FDA Link 08/2006 - 04/2006
1	SolitomabIBA 01/2023
1	EnzymesIBA 01/2023
1	Fluorescein (Funduscein)FDA LinkGeneric 03/2022
1	IsotopesIBA 03/2022
1	Cancer VaccinesIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Pregnancy-Associated Plasma Protein-A (PAPP-A)IBA 01/2022
1	5'-Nucleotidase (5' Nucleotidase)IBA 08/2021
1	Androgen Receptors (Androgen Receptor)IBA 01/2021
1	enzalutamideIBA 01/2021
1	Viral ProteinsIBA 01/2020
1	Programmed Cell Death 1 ReceptorIBA 11/2019
1	blinatumomabIBA 01/2019
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2019
1	durvalumabIBA 01/2018
1	Fluorescein-5-isothiocyanate (FITC)IBA 10/2017
1	Granzymes (Granzyme)IBA 03/2016
1	human ERBB2 proteinIBA 01/2016
1	Estrogens (Estrogen)FDA Link 01/2016
1	Progesterone FDA LinkGeneric 01/2016
1	CalreticulinIBA 01/2015
1	Therapeutic UsesIBA 01/2015
1	Immunoglobulin Fab FragmentsIBA 01/2015
1	Complement System Proteins (Complement)IBA 01/2015
1	Galectins (Galectin)IBA 01/2015
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 11/2014
1	Photosensitizing Agents (Photosensitizers)IBA 10/2014
1	Bleomycin (Blenoxane)FDA LinkGeneric 10/2014

Therapy/Procedure

19	Therapeutics 07/2023 - 09/2004
12	Immunotherapy 01/2023 - 04/2002
4	Drug Therapy (Chemotherapy) 10/2018 - 01/2010
2	Computer-Assisted Surgery (Image Guided Surgery) 11/2014 - 06/2014
2	Radiotherapy 10/2013 - 05/2006
1	Cytoreduction Surgical Procedures 01/2022
1	Hyperthermic Intraperitoneal Chemotherapy 01/2022
1	Aftercare (After-Treatment) 01/2018
1	Photochemotherapy (Photodynamic Therapy) 10/2014